Picture of Biorestorative Therapies logo

BRTX — Biorestorative Therapies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Biorestorative Therapies Announces Clinical Site Initiation For Co's Phase 2 Clinical Trial To Treat Chronic Lumbar Disc Disease

June 13 (Reuters) - BioRestorative Therapies Inc  BRTX.O :
    * BIORESTORATIVE THERAPIES ANNOUNCES CLINICAL SITE
INITIATION FOR
THE COMPANY’S PHASE 2 CLINICAL TRIAL TO TREAT CHRONIC LUMBAR
DISC DISEASE (CLDD)
    * BIORESTORATIVE THERAPIES INC- DENVER SPINE AND PAIN
INSTITUTE IS
FIRST CLINICAL SITE TO BE INITIATED
    * BIORESTORATIVE THERAPIES INC- ADDITIONAL SELECTED SITES
ARE
EXPECTED TO BE INITIATED IN 2022

Source text for Eikon:  ID:nGNX6hrn9R 
Further company coverage:  BRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Biorestorative Therapies

See all news